PharmaBoardroom

Pharma Faces: Paolo Carli, Merck MEAR

Paolo Carli, head of Middle East, Africa, Turkey, Russia and CIS (MEAR) for Merck has continually taken on greater responsibilities in the Middle…

Marc Ayers – CEO, Romark Puerto Rico

Based in Tampa, Florida, Romark is a research-based pharmaceutical company focused on developing innovative treatments for infectious diseases. The…

Paolo Carli – Head of MEAR – Middle East, Africa, Turkey,…

Since we last met with Paolo Carli in 2013, he has been given greater responsibilities within Merck and is now Head of Middle East, Africa, Turkey,…

Collaboration: The IFPMA’s Route to Reaching the…

With sustainable development goals in mind, the global umbrella pharmaceutical association IFPMA has recently launched a platform that fosters…

Gujarat: The Home of Indian Pharma

The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the country’s pharmaceutical turnover…

US FDA’s Efforts to Advance the Development of Gene Therapy

Peter Marks, director of the US FDA's Center for Biologics Evaluation and Research, outlines how the organization is attempting to further promote the…

Dante Castillo – Director of Operations, Sartorius Stedim…

In June 2019, Sartorius Stedim Biotech inaugurated the USD 130 million expansion of its Yauco site, one of the first multi-million dollar investment…

Christina M. Busmalis of IBM Watson Health

IBM Watson Health’s Director for Global Life Sciences & Go-To Market Leader for Europe & Asia Pacific Christina Busmalis gives her insights…

Biosimilars Work. Why Aren’t They Taking Off in the US?

The AAM’s Chip Davis examines the roadblocks to greater adoption of biosimilar drugs in the USA, and why they need to be removed to potentially save…

Three Basic Truths About the US Healthcare System

AstraZeneca's Rick R. Suarez looks at workable solutions to the challenges facing healthcare in the US and why inter-stakeholder collaboration, rather…

Debbie Hart – Founding President & CEO, BioNJ, USA

BioNJ’s president and CEO Debbie Hart reflects on the association’s mission of creating a robust and engaging life sciences ecosystem in New…

Cybersecurity: A Health Business Risk Requiring Executive…

Carla Smith looks at the various cybersecurity risks that exist across the US healthcare continuum and the steps that executive leadership can take to…

Tagged with US